Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> China Pharma Providers
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
China Pharma Providers
Type:
CRO-Preclinical
Title:
Biotech Pharmaceutical Co Ltd
Chinese
CSertification:
n/a
International
Certification:
n/a
Primary Location:
Beijing
China
Contact Info:
n/a
Webpage:
www.biotechplc.com
HQ
Contact Info:
No.2 Rong Jing Dong Jie, Beijing Economic & Technological Development Area, Beijing 100176, China
Tel: +86 10 5157 1020; 51571022 Fax: +86 10 51571026
Email: biotech@biotechplc.com
Additional
Contact Info:
n/a
Description:
Founded in August 1st, 2000, Biotech Pharma is a high-tech Sino-Cuban joint venture. The company is dedicated in research, development and production of monoclonal antibodies for treatment of malignant tumors.
Biotech Pharma is constructed a research and production base in BDA, which includes a mammalian cell culture technology platform with the largest scale, the finest equipments and the most advanced technologies in China. The company is supported by the China National Development and Reform Commission as a demonstrating project of high-tech industry.
The featuring product of the company is a novel targeting anticancer drug, Taixinsheng
®
Humanized Anti-epidermal Growth Factor Receptor Monoclonal Antibody, which is a key project in the "National High-tech Research and Development (863) Plan".
Founded in December 5th, 1994, Center for Molecular Immunology (CIM) is located in the west of Havana City, mainly working in research and manufacture of cancer drugs and others chronic noninfectious biological medicine. The design and construction of CIM are fully under WHO (World Healthy Organization) recommended cGMP standard, same with which is using in the most European countries. CIM occupies 15,000 square meters and has more than 500 personnel, most of them are scientists or engineers in the three major departments: R&D, Production, QA.
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit